Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05730543 · ClinicalTrials.gov registry record · Phase 3

Ethnic Lip Augmentation With Hyaluronic Acid Filler

A Phase 3 study, sponsored by DeNova Research.

Completed
Registry status
Phase 3
Development phase
20
Enrollment target

NCT05730543: Completed Phase 3 study, sponsored by DeNova Research.

NCT05730543 is a Phase 3 study that has completed, run by DeNova Research. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05730543, a Phase 3 study, has completed, sponsored by DeNova Research.

COMPLETED
Registry status
Phase 3
Development phase
20 participants
Enrollment target

Study Summary

Lip augmentation using hyaluronic acid filler in females with Fitzpatrick skin type V-VI

Primary Outcome

The size of lip most desired based on the LFS scale. The possible choices are: 1) Minimal: flat or nearly flat contour, minimal red lip show. 2) Mild: some red lip show, no lower lip pout. 3) Moderate: Moderate red lip show with slight lower lip pout. 4) Marked: significant red lip show and lower lip pout, upper lip with moderate pout. 5) Very Marked: very significant red lip show, significant upper and lower lip pout.

Interventions

  • DRUG Volbella or Juvederm Ultra XC filler

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-11-01
Est. Completion 2023-07-01
Phase Phase 3
DeNova Research

18 total trials

What the finished NCT05730543 record still lists

NCT05730543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Volbella or Juvederm Ultra XC filler is the first listed.

NCT05730543 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05730543 about?

NCT05730543 is a clinical study titled "Ethnic Lip Augmentation With Hyaluronic Acid Filler". Lip augmentation using hyaluronic acid filler in females with Fitzpatrick skin type V-VI

What is the current status of trial NCT05730543?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2022-11-01. Estimated completion is 2023-07-01.

What interventions are being tested in trial NCT05730543?

The interventions under investigation include: Volbella or Juvederm Ultra XC filler (DRUG).

Who is sponsoring clinical trial NCT05730543?

This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05730543's enrollment target sits among peer trials

20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05730543, the US trial registry maintained by the National Library of Medicine. NCT05730543 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.